Tag Archives: McKesson

Specialty Drug, Specialty Pharmacy

Biologics by McKesson Selected to Provide TRUSELTIQ and LUMAKRAS

Posted on by John Santilli
22
Jun

Biologics specialty pharmacy teams includes pharmacists with in-depth knowledge of therapies, experienced nurses, and financial counselors who are familiar with various financial assistance programs and organizations that help patients

Continue reading →
Biopharma, Specialty Drug, Specialty HUBs

CoverMyMeds to Play a Major Role in McKesson’s BioPharma Services Strategy

Posted on by John Santilli
27
May

McKesson recently announced that RelayHealth, McKesson Prescription Automation, CoverMyMeds, and RxCrossroads by McKesson, are coming together as one brand under the CoverMyMeds umbrella.

Continue reading →
Specialty Drug, Specialty Pharmacy

AmerisourceBergen Introduces a PSAO Focused on Specialty Pharmacy

Posted on by John Santilli
15
Apr

AmerisourceBergen recently introduced Accelerate Specialty Network, a PSAO the company said is the first to focus on specialty pharmacy

Continue reading →
Oncology, Specialty Pharmacy, Uncategorized

Biologics by McKesson Expands Oncology Practices Offerings

Posted on by John Santilli
23
Mar

Biologics has contracted with more than 500 payers and offers more than 150 therapies

Continue reading →
Distribution, Oncology, Specialty Drug

US Oncology Expands Reach By Adding Two Oncology Practices

Posted on by John Santilli
23
Oct

US Oncology helps independent physicians deliver value-based, integrated care to patients

Continue reading →
Oncology, Specialty Drug, Specialty Pharmacy

Biologics by McKesson and AllianceRx Expand Specialty Pharmacy Oncology Offerings

Posted on by John Santilli
31
Aug

INQOVI is for the treatment of adults with intermediate and high-risk myelodysplastic syndromes (MDS) including chronic myelomonocytic leukemia (CMML), two blood malignancies

Continue reading →
Oncology, Specialty Drug, Specialty Pharmacy

Biologics by McKesson Expands Specialty Pharmacy Oncology Offerings

Posted on by John Santilli
26
Aug

Biologics, as part of a recent reorganization, is now joining McKesson’s Provider Solutions business within the Pharmaceutical Solutions and Services (PSaS) business unit

Continue reading →